Ultrahypofractionated Adjuvant Breast Radiation Therapy (± Boost) and Virtual Consultations: Patient Perspectives at 1 Year
Ultrahypofractionated breast radiation therapy leads to acceptable late toxicity at 1 year, even when followed by a hypofractionated tumor bed boost. Patient satisfaction with ultrahypofractionated treatment and virtual consultations without video was high. Further investigation concerning the patient's acceptance of video consultations for a physician-based assessment, including breast inspection, is warranted.
Authors
- Jill Nicholson (ORCID: https://orcid.org/0009-0000-7301-3329)
- Sinéad Cleary
- Killian Nugent
- Orla McArdle
- Gemma Farmer
- E. Quinlan
- Hannah O’ Driscoll
- Orla Monaghan
- Bahareh Khosravi
- Frances Duane (ORCID: https://orcid.org/0000-0001-7838-5957)
Institutions
- Royal College of Surgeons in Ireland (IE)
- Trinity College Dublin (IE)
- St. Luke's Hospital (IE)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1016/j.adro.2024.101668
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- St. Luke's Institute of Cancer Research